Newcomb FM - Search Results

1

Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.

Humphrey RW, O'Brien TR, Newcomb FM, Nishihara H, Wyvill KM, Ramos GA, Saville MW, Goedert JJ, Straus SE, Yarchoan R. Humphrey RW, et al. Among authors: newcomb fm. Blood. 1996 Jul 1;88(1):297-301. Blood. 1996. PMID: 8704186 Free article.

2

Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.

Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. J Infect Dis. 1997 May;175(5):1071-9. doi: 10.1086/516444. J Infect Dis. 1997. PMID: 9129068

3

Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases.

Humphrey RW, Davis DA, Newcomb FM, Yarchoan R. Humphrey RW, et al. Among authors: newcomb fm. Leuk Lymphoma. 1998 Jan;28(3-4):255-64. doi: 10.3109/10428199809092681. Leuk Lymphoma. 1998. PMID: 9517497 Review.

4

Activity of thalidomide in AIDS-related Kaposi's sarcoma.

Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R. Little RF, et al. Among authors: newcomb fm. J Clin Oncol. 2000 Jul;18(13):2593-602. doi: 10.1200/JCO.2000.18.13.2593. J Clin Oncol. 2000. PMID: 10893291 Clinical Trial.

5

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

Perno CF, Newcomb FM, Davis DA, Aquaro S, Humphrey RW, Caliò R, Yarchoan R. Perno CF, et al. Among authors: newcomb fm. J Infect Dis. 1998 Aug;178(2):413-22. doi: 10.1086/515642. J Infect Dis. 1998. PMID: 9697721

6

Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro.

Davis DA, Newcomb FM, Starke DW, Ott DE, Mieyal JJ, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. J Biol Chem. 1997 Oct 10;272(41):25935-40. doi: 10.1074/jbc.272.41.25935. J Biol Chem. 1997. PMID: 9325327 Free article.

7

Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.

Davis DA, Yusa K, Gillim LA, Newcomb FM, Mitsuya H, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. J Virol. 1999 Feb;73(2):1156-64. doi: 10.1128/JVI.73.2.1156-1164.1999. J Virol. 1999. PMID: 9882317 Free PMC article.

8

Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.

Davis DA, Read-Connole E, Pearson K, Fales HM, Newcomb FM, Moskovitz J, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. Antimicrob Agents Chemother. 2002 Feb;46(2):402-8. doi: 10.1128/AAC.46.2.402-408.2002. Antimicrob Agents Chemother. 2002. PMID: 11796349 Free PMC article.

9

HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase.

Davis DA, Newcomb FM, Moskovitz J, Wingfield PT, Stahl SJ, Kaufman J, Fales HM, Levine RL, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. Biochem J. 2000 Mar 1;346 Pt 2(Pt 2):305-11. Biochem J. 2000. PMID: 10677347 Free PMC article.

10

Reversible oxidation of HIV-2 protease.

Davis DA, Newcomb FM, Moskovitz J, Fales HM, Levine RL, Yarchoan R. Davis DA, et al. Among authors: newcomb fm. Methods Enzymol. 2002;348:249-59. doi: 10.1016/s0076-6879(02)48643-0. Methods Enzymol. 2002. PMID: 11885278 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters